Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico |
Cuevas-Gonzalez, Maria Veronica
(Department of Maxillofacial Prosthetics, General Hospital of Mexico)
Diaz-Aguirre, Celia Minerva (Department of Maxillofacial Prosthetics, General Hospital of Mexico) Echevarria-y-Perez, Enrique (Department of Maxillofacial Prosthetics, General Hospital of Mexico) Cuevas-Gonzalez, Juan Carlos (Department of Stomatology, Institute of Biomedical Sciences, Autonomous University of Ciudad Juarez) |
1 | Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg 2009;67(5 Suppl):2-12. DOI |
2 | Fuentes R, Borie E, Sanhueza Campos A, Rebolledo Soto K, Parra Villagran P. Presencia de exostosis orales en pacientes de la ciudad de Temuco, Chile. Avances Odontoestomatol 2012;28:63-9. DOI |
3 | de la Fuente-Hernandez J, Gonzalez de Cossio M, Ortega-Maldonado M, Sifuentes-Valenzuela MC. Caries y perdida dental en estudiantes preuniversitarios mexicanos [Dental decay and tooth loss at the high school level in Mexican students]. Salud Publica Mex 2008;50:235-40. |
4 | Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bisphossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 2005;63:682-9. DOI |
5 | Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 2010;136:1117-24. DOI |
6 | Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22:1479-91. DOI |
7 | Marx RE. Oral & intravenous bisphosphonate-induced osteonecrosis of the jaws: history, etiology, prevention, and treatment. Hanover Park: Quintessence Publishing; 2007:1-65. |
8 | Correia Vde F, Caldeira CL, Marques MM. Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts. Dent Traumatol 2006;22:312-7. DOI |
9 | Kim KM, Rhee Y, Kwon YD, Kwon TG, Lee JK, Kim DY. Medication related osteonecrosis of the jaw: 2015 position statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab 2015;22:151-65. DOI |
10 | Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369-76. DOI |
11 | Kos M. Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. Arch Med Sci 2015;11:319-24. |
12 | Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos Int 2013;24:237-44. DOI |
13 | Casal C, Someso E, Alvarez AM, Farina J, Alvarez T. Osteonecrosis de maxilares relacionada con el uso de bifosfonatos [Osteonecrosis of the jaws related with the use of bisphosphonates]. Farmaceuticos de Atencion Primaria 2012;10:9-14. DOI |
14 | Varun B, Sivakumar T, Nair BJ, Joseph AP. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: a systematic review. J Oral Maxillofac Pathol 2012;16:210-4. DOI |
15 | Lee JK, Kim KW, Choi JY, Moon SY, Kim SG, Kim CH, et al. Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg 2013;39:9-13. DOI |
16 | Chang JI, Hazboun RC, Chang TI. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 2014;72:2381. |
17 | Arce C, Bargallo E, Villasenor Y, Gamboa C, Lara F, Perez V, et al. Oncoguia: Cancer de Mama. Mexico City: Instituto Nacional de Cancerologia; 2011:77-86. |
18 | Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S. Breast cancer in Mexican women under 40. Ginecol Obstet Mex 2011;79:482-8. |
19 | Bonacina R, Mariani U, Villa F, Villa A. Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc 2011;77:b147. |
20 | Junquera LM, Martin-Granizo R. Diagnostico, prevencion y tratamiento de la osteonecrosis de los maxilares por bisfosfonatos. Recomendaciones de la Sociedad Española de Cirugia Oral y Maxilofacial (SECOM). Rev Esp Cir Oral y Maxilofac 2008;30:145-56. |
21 | Khamaisi M, Regev E, Yarom N, Avni B, Leitersdorf E, Raz I, et al. Possible association between diabetes and bisphosphonaterelated jaw osteonecrosis. J Clin Endocrinol Metab 2007;92:1172-5. DOI |